You can buy or sell AbbVie and other stocks, options, ETFs, and crypto commission-free!
ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. Read More The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
North Chicago, Illinois
52 Week High
52 Week Low
Yahoo FinanceJun 2
MARKETS: Dow surges into the close, up 268 points — YF Premium is bullish on Abbvie
Yahoo Finance's Jared Blikre joins Seana Smith to break down the day's price action in stocks as well as a long in Abbvie (ABBV), a Yahoo Finance Premium Invest
BRIEF-Abbvie And Jacobio Announce Strategic Collaboration To Advance Shp2 Inhibitors
June 1 (Reuters) - Abbvie Inc: * ABBVIE AND JACOBIO ANNOUNCE STRATEGIC COLLABORATION TO ADVANCE SHP2 INHIBITORS * UNDER TERMS OF AGREEMENT, ABBVIE WILL BE GRA
— per share
Expected Jul 24, Pre-Market